U.S. military implantable collamer lens surgical outcomes: 11-year retrospective review

Packer, Kyle; Vlasov, Anton; Greenburg, David; Coggin, Andrew; Weightman, James; Beltran, Thomas; Berry‐Cabán, Cristóbal S.; Carroll, R. B.

doi:10.1097/j.jcrs.0000000000000818

Cited by 23 publications

(36 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The sudden increase in intraocular pressure will split the transparent corneal incision that has healed after ICL implantation, and then, the iris will be expelled from the eye [160]. Packer KT et al had a similar report [114].…”

Section: Traumatic Prolapse Of Irismentioning

confidence: 99%

“…The incidence increases with the passage of postoperative time [68,74,77,84,142,[163][164][165][166][167][168][169]. It has been reported that the incidence of cataract within 10 years after ICL implantation is 12.1% [78] and the risk of cataract formation will increase seven years after ICL implantation [114]. Ohoud Owaidhah et al also reported a case of bilateral cataract 4 months after ICL implantation for both eyes [170], while the longest reported cataract caused by ICL implantation is 10 years after surgery.…”

Section: Cataractmentioning

confidence: 99%

See 1 more Smart Citation

Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation

et al. 2022

View full text Add to dashboard Cite

Purpose To introduce a modified procedure of ICL implantation, to summarize the perioperative problems and their corresponding treatment after myopia correction with Implantable Collamer Lens (ICL), and to compare the difference of complications between the no-hole ICL and hole ICL. Methods We searched all articles on ICL-related perioperative problems and their corresponding treatment in Scopus, Embase, PubMed and Web of Science databases for the last 22 years. Results ICL implantation is safe, effective, stable and predictable in the correction of myopia, hyperopia and astigmatism, but can also cause a series of perioperative problems, including intraoperative and postoperative complications. Conclusion There are many kinds of complications related to ICL, but the common intraoperative and postoperative complications mainly include abnormality of arch height, abnormal position of ICL, loss of corneal endothelial cells and corneal decompensation, high intraocular pressure and secondary glaucoma, cataract and night vision symptoms. Compared with ICL without central pore, the incidence of complications such as loss of corneal endothelial cells and corneal decompensation, high intraocular pressure and secondary glaucoma and cataract was relatively lower in central hole ICL, while postoperative complications such as night vision symptoms were obvious.

show abstract

Section: Traumatic Prolapse Of Irismentioning

confidence: 99%

Section: Cataractmentioning

confidence: 99%

Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Moreover, only 2/3105 eyes developed glaucoma after ICL surgery in a 11-year retrospective study. 69 In a previous review, although there were no data indicating increased IOP, the author found that pupillary block occurred in only 0.04% of the eyes. 46 In a recent series of 2283 V4c-model ICL procedures, only three eyes underwent ICL exchange/explantation due to uncontrolled ocular hypertension, supporting that persistent IOP elevation after hole-ICL implantation is rare.…”

Section: Resultsmentioning

confidence: 94%

“…32 Studies evaluating hole-ICL models reported ECC loss ranging 0.1-2.8% within 1 year postoperatively, 32,36,38,39,71 while it ranged from 0.43% to 21.8% decline in the final visit for studies with a follow-up of at least 4 years. 40,[50][51][52]69,72,73 The number of corneal endothelial cells tended to deteriorate more rapidly during the first year after ICL implantation. 74 In the US-FDA trial, ECC loss ranged from 8.4% to 9.7% in the first 3 years postoperatively and stabilized thereafter.…”

Section: Corneal Endothelial Cell Lossmentioning

confidence: 99%

Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes

Wannapanich¹,

Kasetsuwan²,

Reinprayoon³

2023

OPTH

View full text Add to dashboard Cite

This review summarizes the available literature and provides updates on the efficacy, safety, and patient outcomes of phakic intraocular lens implantation using implantable collamer lens (ICL), with a focus on newer models with a central port (EVO/EVO+ Visian Implantable Collamer Lens, STAAR Surgical Inc.). All studies included in this review were identified from the PubMed database and were reviewed for relevancy of their topic. Data on hole-ICL implantation performed between October 2018 and October 2022 in 3399 eyes showed a weighted average efficacy index of 1.03 and a weighted average safety index of 1.19 within an average follow-up of 24.7 months. The incidence of complications such as elevated intraocular pressure, cataract, and corneal endothelial cell loss was low. Moreover, both quality of vision and quality of life improved after ICL implantation, confirming the benefits of this procedure. In conclusion, ICL implantation is a promising refractive surgery alternative to laser vision correction with excellent efficacy, safety, and patient outcomes.

show abstract

“…Despite the excellent long-term efficacy and safety profiles of phakic intraocular lenses (PIOLs) for the correction of moderate-to-high ametropia, [1][2][3][4] accelerated endothelial cell loss is still the main concern after PIOL implantation, 4,5 being the second most frequent indication for PIOL explantation (after cataract development). [6][7][8][9][10] Up to 3-4% of patients with PIOL-related corneal decompensation may require corneal allograft transplantation.…”

Section: Introductionmentioning

confidence: 99%

Descemet’s Membrane Endothelial Keratoplasty for Corneal Endothelial Failure Secondary to Three Types of Phakic Intraocular Lens – Retrospective Study

Moura-Coelho¹,

Cunha²,

Dias‐Santos³

et al. 2023

OPTH

View full text Add to dashboard Cite

Purpose To analyze the outcomes of Descemet’s membrane endothelial keratoplasty (DMEK) for corneal endothelial failure secondary to phakic intraocular lens implantation (PIOL) at a reference center for corneal transplantation in Spain. Design Retrospective, single-surgeon case series. Methods Single-center analysis of patients who underwent DMEK for PIOL-related corneal decompensation between July 2011 and July 2020 with at least 6 months of follow-up postoperatively. Primary outcome was final best-corrected visual acuity (BCVA, logMAR) compared to pre-DMEK BCVA. Secondary outcomes analyzed included post-DMEK refractive spherical equivalent, endothelial cell loss (%ECL), and graft failure. Results Sixteen eyes (14 patients) underwent DMEK for PIOL-related corneal decompensation. Mean (SD) time to PIOL explantation was 9.3 (5.0) years, and median (P25-P75) time between PIOL explantation and DMEK surgery was 3 (2–4) months. Median pre-DMEK BCVA was 0.80 (1.08–0.60) logMAR. A statistically significant improvement in BCVA was observed 1 month after DMEK (p = 0.001), and median final BCVA was 0.15 (0.0–0.35) logMAR (p = 0.002). Mean %ECL was 55.6 (18.7) % at 2-year follow-up and 61.7 (11.7) % in eyes with over 4 years of follow-up. Two eyes required re-bubbling (12.5%), one of which ended in primary graft failure (6.2%) and one eye had late endothelial graft failure (LEGF) at 4-year follow-up (1/15 grafts, 6.7%). Conclusion In patients with PIOL-related corneal decompensation, DMEK leads to good and clinically significant refractive and visual outcomes in the medium-long term, with a good safety profile. Prospective studies are encouraged to ascertain whether these cases are at increased risk of accelerated endothelial cell loss and LEGF.

show abstract

U.S. military implantable collamer lens surgical outcomes: 11-year retrospective review

Abstract: To examine the long-term efficacy and safety of myopic implantable collamer lens (ICL) implantation in active duty personnel of U.S. military.

Cited by 23 publications

References 35 publications

Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation

Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation

Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes

Descemet’s Membrane Endothelial Keratoplasty for Corneal Endothelial Failure Secondary to Three Types of Phakic Intraocular Lens – Retrospective Study

Contact Info

Product

Resources

About